Back to Screener

Industrials

CompoSecure, Inc.(CMPOW)

Live Price

Offline

$12.15

+2.35% today

Window Change

+93.78%

Window

Jun 23, 2025 โ†’ Dec 3, 2025

Market Cap
$2.08B
Revenue Growth
-85.8%
EPS Growth
+11.5%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 112 bars ยท Jun 23, 2025 โ†’ Dec 3, 2025

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

CompoSecure, Inc. (CMPOW) is a Industrials stock with a market cap of $2.08B. The stock last traded around $12.15 and up 93.8% across the available one-year price window (Jun 23, 2025 โ†’ Dec 3, 2025). Baseline metrics include revenue growth of -85.8%, EPS growth of +11.5%, a dividend yield of 0.0%. What stands out right now is revenue -85.8%, EPS +11.5%, free cash flow -119.4% with operating margin -23.0% and ROIC -2.7%. The dividend is present but secondary, with a yield around 0.0%. Valuation already assumes a fairly strong business story at price/sales 80.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CMPOW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

CMPOW

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

CMPOW Max Drawdown

-17.51%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CMPOW and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

CompoSecure, Inc. (CMPOW)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$267.9M

-29.2% YoY

FY Net Income

$3.2M

-83.1% YoY

Free Cash Flow

$73.0M

-12.8% YoY

Revenue Growth

-85.8%

EPS Growth

+11.5%

Gross Margin

48.1%

Net Margin

-227.3%

Income statement

USD

Annual
Metric20252024202320222021
Revenue60M421M391M378M268M
Gross Profit29M219M209M220M145M
Operating Income-14M108M119M115M81M
EBITDA-12M-51M155M167M105M
Net Income-136M-54M19M19M3M
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20252024202320222021
Cash & Equivalents115M77M41M14M22M
Total Assets517M478M201M163M131M
Total Liabilities274M622M407M455M539M
Shareholder Equity243M-143M-802M-892M-1.0B
Total Debt0206M351M375M398M
Net Debt-115M128M310M362M376M

Cash flow positioning

Latest Full Year

Operating Cash Flow

78M

-16.2% YoY

Capital Expenditures

5M

+47.6% YoY

Free Cash Flow

73M

-12.8% YoY

Key ratios

  • Gross Margin

    48.1%

  • Operating Margin

    -23.0%

  • Net Margin

    -227.3%

  • ROE

    -269.4%

  • Debt / Equity

    0.00x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.